Misonix, a developer of minimally invasive ultrasonic medical device technology, is restructuring and expanding its sales organization in Europe, creating two separate business units.
One of the new units will be for sales and service of the Sonablate 500 high intensity focused ultrasound (HIFU) system and the other for sales and service of the SonaStar ultrasonic surgical aspirator, the BoneScalpel ultrasonic bone cutting system and the SonicOne ultrasonic wound cleansing and debridement system.
The Farmingdale, N.Y.-based company said its new Misonix HIFU Technologies unit, which will be headed by Nick Stevens, will focus on a "fee for use" business model that will feature a combination of mobile services delivered directly to hospitals and facilities to which qualified patients can be referred. Its U.K. HIFU and Misonix France business units, which were created to support the "fee for service" business model, will be integrated into Misonix HIFU Technologies and overseen by the same management team.
Misonix EMEA [Europe, Middle East, Africa] will continue to sell and service the company's non-HIFU product platforms through specialty distributors and continue to be managed by Patrick Kyne, according to the firm.